drugdiscovery.pharmaceutical-business-review.comDrug Discovery Archives - Pharmaceutical Business review

-- Pharmaceutical Business review -- -- Pharmaceutical Business review is using cookies Continue Learn More Close ☰ Search × Home About Us Add Company Advertise with us Contact us Events Suplpiers News Clinical Trials Drug Discovery Packaging & Supply Chain Production & Sales Regulation Advertise With Us Advertise on our extensive network of industry websites and newsletters. Get the PBR newsletter Sign up to our free email to get all the latest PBR news. Home Drug Discovery Drug Discovery Research & Development Pre-clinical Studies Research & Development CBDepot Research & Development Pfizer acquires Amplyx Pharmaceuticals Research & Development Clinical Trials Clinical Trials Patient Enrollment Human Trials Patient Enrollment AM-Pharma enrols first patients in Covid-19 phase III trial Clinical Trials Patient Enrollment FSD Pharma doses first patient in phase 2 Covid-19 trial of FSD201 Clinical Trials Patient Enrollment Regulation Regulation Drug Filing Approvals Rejections Marketing Authorisation Patents Lawsuits Drug Filing Takeda submits New Drug Application for lanadelumab in Japan Drug Filing Approvals Haematology Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US Regulation Drug Filing Production & Sales Production & Sales Production & Sales Manufacturing Launches Recalls Marketing & Sales Manufacturing SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China Manufacturing Marketing & Sales Neurology Biogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806 Manufacturing Osteoarthritis Packaging & Supply Chain Packaging & Supply Chain Packaging Cold Chain Distribution Storage Packaging Gerresheimer Packaging PCI Pharma announces bottling line expansion at Rockford site Packaging & Supply Chain Packaging Suppliers Suppliers A-Z Suppliers Products & Services Videos White Papers No data found Events -- Register Log In Drug Discovery 20 May 2021 Drug Discovery Exscientia expands AI-based drug discovery alliance with BMS By vbandhakavi Exscientia and Bristol-Myers Squibb agree to leverage AI to discover drug candidates for various diseases. 19 May 2021 Research & Development CBDepot By rpanks CBDepot produces high-quality natural cannabinoid ingredients and cannabinoid-enriched products for the industrial and consumer market. 12 May 2021 Drug Discovery Lilly, MiNA Therapeutics partner to develop new drug candidates By vbandhakavi Eli Lilly and Company and MiNA Therapeutics are set to develop new drug candidates as part of a global research collaboration. 29 Apr 2021 Research & Development Pfizer acquires Amplyx Pharmaceuticals By PBR Staff Writer Pharmaceutical company Pfizer has acquired a privately held company Amplyx Pharmaceuticals for an undisclosed amount. 23 Apr 2021 Drug Discovery Vertex and Obsidian partner to discover gene-editing medicines By vbandhakavi Vertex Pharmaceuticals and Obsidian Therapeutics have established a multi-year collaboration for the discovery of new treatments that regulate gene editing. 07 Apr 2021 Drug Discovery AB Science and University of Chicago to conduct Covid-19 treatment research By PBR Staff Writer French pharmaceutical company AB Science has signed an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19 with masitinib and its other proprietary drugs. 31 Mar 2021 Drug Discovery Amgen agrees to acquire biopharmaceutical company Rodeo Therapeutics By PBR Staff Writer Biotechnology company Amgen has agreed to acquire privately held biopharmaceutical company Rodeo Therapeutics. 12 Mar 2021 Biotechnology Research & Development Clinical Trials NIAID grants $2.5m to 12 institutes for bacteriophage therapy research By PBR Staff Writer A branch of the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) has granted $2.5m to 12 institutes across the world for bacteriophage therapy research. 04 Mar 2021 Research & Development Infectious Disease Bharat Biotech’s Phase III interim results of COVAXIN demonstrate efficacy of 81% By vbandhakavi Biopharmaceutical company Ocugen has announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase 3 study of COVAXIN, which is a whole virion inactivated Covid vaccine candidate. 02 Mar 2021 Drug Discovery Research & Development Boehringer Ingelheim, Gubra to validate new Peptides for obesity By PBR Staff Writer Boehringer Ingelheim has entered into a new research and licensing agreement with biotech company Gubra to identify and validate innovative peptides to treat obesity. -- -- About Us Advertise with us Contact us PRIVACY POLICY TERMS AND CONDITIONS © PBR 2021. Part of Progressive Trade Media Ltd. Lost Password Back ⟶ Login Register Get new password Lost Password? Login Registration is disabled....